1 min read.Updated: 25 Sep 2019, 03:45 PM ISTLivemint
Ranitidine has been available in India over the counter for a long time, and is worth an estimated ₹688.6 crore in sales
Watch what you pop into your mouth. Ranitidine, the favourite antacid of workaholics who have little time to grab a bite and must clamp their acid secretions, may be dangerous. The US regulator of drugs has reported that it found a carcinogenic impurity called N-nitrosodimethylanine (NDMA) in it. This has prompted the Drug Controller General of India (DCGI) to issue a warning to state drug regulators and domestic pharma companies to test their products for this impurity and to sell the drug only on prescriptions. The drug is popularly known as Zantac worldwide (Zinetac in India), the brand under which it achieved blockbuster status in the US some decades ago. Today, generic versions of it are found in medicine cabinets everywhere.
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.